Vilaplana R, Basallote M G, González-Vilchez F
Rev Esp Oncol. 1984;31(4):575-82.
The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.
作者讨论了使用钌配合物作为潜在抗肿瘤药物的便利性，以及这些物质在其生物活性方面的重要意义。报道了该类新药的合成及其对荷艾氏腹水癌小鼠给药的结果。
